Search by Drug Name or NDC
NDC 72850-0007-02 Cebashin Cap. 356; 710; 356; 426; 710; 284; 426; 426; 22; 284 mg/10g; mg/10g; mg/10g; mg/10g; mg/10g; mg/10g; mg/10g; mg/10g; mg/10g; mg/10g Details
Cebashin Cap. 356; 710; 356; 426; 710; 284; 426; 426; 22; 284 mg/10g; mg/10g; mg/10g; mg/10g; mg/10g; mg/10g; mg/10g; mg/10g; mg/10g; mg/10g
Cebashin Cap. is a ORAL CAPSULE in the HUMAN OTC DRUG category. It is labeled and distributed by Chunwoo Pharmaceutical Co., Ltd.. The primary component is ARCTIUM LAPPA FRUIT; FORSYTHIA SUSPENSA FRUIT; GLYCINE MAX WHOLE; LICORICE; LONICERA JAPONICA WHOLE; LOPHATHERUM GRACILE TOP; MENTHA ARVENSIS TOP; PLATYCODON GRANDIFLORUS ROOT; SAIGA TATARICA HORN; SCHIZONEPETA TENUFOLIA SPIKE.
Product Information
NDC | 72850-0007 |
---|---|
Product ID | 72850-0007_d6e992e3-5ca4-17fe-e053-2a95a90ae31b |
Associated GPIs | |
GCN Sequence Number | n/a |
GCN Sequence Number Description | n/a |
HIC3 | n/a |
HIC3 Description | n/a |
GCN | n/a |
HICL Sequence Number | n/a |
HICL Sequence Number Description | n/a |
Brand/Generic | n/a |
Proprietary Name | Cebashin Cap. |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | FORSYTHIA SUSPENSA FRUIT, LONICERA JAPONICA WHOLE, MENTHA ARVENSIS TOP, PLATYCODON GRANDIFLORUS ROOT, LICORICE, ARCTIUM LAPPA FRUIT, GLYCINE MAX WHOLE, LOPHATHERUM GRACILE TOP, SCHIZONEPETA TENUFOLIA SPIKE, SAIGA TATARICA HORN |
Product Type | HUMAN OTC DRUG |
Dosage Form | CAPSULE |
Route | ORAL |
Active Ingredient Strength | 356; 710; 356; 426; 710; 284; 426; 426; 22; 284 |
Active Ingredient Units | mg/10g; mg/10g; mg/10g; mg/10g; mg/10g; mg/10g; mg/10g; mg/10g; mg/10g; mg/10g |
Substance Name | ARCTIUM LAPPA FRUIT; FORSYTHIA SUSPENSA FRUIT; GLYCINE MAX WHOLE; LICORICE; LONICERA JAPONICA WHOLE; LOPHATHERUM GRACILE TOP; MENTHA ARVENSIS TOP; PLATYCODON GRANDIFLORUS ROOT; SAIGA TATARICA HORN; SCHIZONEPETA TENUFOLIA SPIKE |
Labeler Name | Chunwoo Pharmaceutical Co., Ltd. |
Pharmaceutical Class | n/a |
DEA Schedule | n/a |
Marketing Category | UNAPPROVED HOMEOPATHIC |
Application Number | n/a |
Listing Certified Through | 2023-12-31 |
Package
Package Images

NDC 72850-0007-02 (72850000702)
NDC Package Code | 72850-0007-2 |
---|---|
Billing NDC | 72850000702 |
Package | 1 CAPSULE in 1 BOX (72850-0007-2) / 10 g in 1 CAPSULE (72850-0007-1) |
Marketing Start Date | 2022-01-12 |
NDC Exclude Flag | N |
Pricing Information | N/A |
Standard Product Labeling (SPL)/Prescribing Information SPL d3c1a869-be57-38a4-e053-2995a90a0d62 Details
Active ingredients
Keep out of reach of children
Warnings
Do not use if you are
- Children under 5 years old
Do not use if you have
- Galactose intolerance
- Lapp lactase deficiency
- Glucose-galactose malabsorption (this medicine contains lactose)
Ask a doctor before use if you
- have hypertension
- have a heart disease or a kidney disease
- a patient with edema
- pregnant or have a chance to pregnant
- a patient who has rashes, bloodshot, redness, itching, and etc. caused by medication
- a patient with significantly weakened stomachs
- an elderly person (in general, elderly people should take with care, such as reducing their dosage, as their physiological function has deteriorated)
- in a post-disease stage (am abnormal reaction can be easily seen and the symptoms can worsen)
- a patient who is being treated by a doctor or are taking other medications
Stop use and ask a doctor, pharmacist or health professionals if
- if there is no improvement in symptoms after taking it for a few days
- you have following symptoms after use:
- Pseudohyperaldosteronism: Reduced urine volume, swollen face, swollen hands and feet, heavy eyelids, firm hands, increased blood pressure, headache, and etc. (Mediciness with a maximum daily dose of 1g or more may develop hypoglycemia, blood pressure rise, low sodium body fluid, edema, weight gain, and etc. caused by pseydohyperaldosteronism if taken continuously for a long time. Therefore, make sufficient observations (measurement of serum potassium levels) and stop taking if there is any abnormality.)
-Myopathy: Myopathy (muscle disease) may occur as a result of hypokalemia, so take sufficient observation and stop taking if you find any abnormalities such as feeling helplessness, limb cramps, paralysis, and etc.
-Skin trouble: a rash, itch, bloodshot, and etc.
-Digestive system disorder: anorexia, stomach discomfort, nausea, vomiting, and etc.
Other Warnings
- do not take more than directed
- if children are to take this medicine, take it under the supervision of their guardian.
- when taken with potassium-containing agents, licorice-containing agents, glycirizinic acid or other related agents, loop diuretics (furosemide, ethacrynic acid), or thiazide diuretics (trichlormethiazide) and myopathy, it is likely to appear due to gastric aldosterone (pseudohyperaldosteronism) or hypokalemia
- If taken with other herbal medicines, be careful of overlapping of the crude medicines.
- In principle, you should not to take it continuously for a long time, but if it is necessary, consult with a doctor, herb doctor, dentist, pharmacist, or other health care professionals.
INGREDIENTS AND APPEARANCE
CEBASHIN CAP.
forsythia suspensa fruit, lonicera japonica whole, mentha arvensis top, platycodon grandiflorus root, licorice, arctium lappa fruit, glycine max whole, lophatherum gracile top, schizonepeta tenufolia spike, saiga tatarica horn capsule |
||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||
|
Labeler - Chunwoo Pharmaceutical Co., Ltd. (688729065) |
Registrant - Chunwoo Pharmaceutical Co., Ltd. (688729065) |
Establishment | |||
Name | Address | ID/FEI | Business Operations |
---|---|---|---|
Chunwoo Pharmaceutical Co., Ltd. | 688729065 | manufacture(72850-0007) |